Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.83 |
| ▸ | PPARG | P37231 | 7/20 | 0.83 |
| ▸ | PPARD | Q03181 | 7/20 | 0.83 |
| ▸ | PPARA | Q07869 | 7/20 | 0.83 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.83 |
| ▸ | TSHR | P16473 | 5/20 | 0.83 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.83 |
| ▸ | TLR2 | O60603 | 2/20 | 0.83 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.83 |
| ▸ | FABP4 | P15090 | 2/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.83 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.83 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.83 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.83 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.83 |
| ▸ | MEN1 | O00255 | 1/20 | 0.83 |
| ▸ | ESR1 | P03372 | 1/20 | 0.83 |
| ▸ | PDE4A | P27815 | 1/20 | 0.83 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octanedioate SCHEMBL1483010 | 1.00 | GPR84 (0.83) | GPR84PPARGPPARDPPARAHDAC11 | |
| Pimelic Acid SCHEMBL1483103 | 1.00 | GPR84 (0.83) | GPR84PPARGPPARDPPARAHDAC11 | |
| Azelaic Acid SCHEMBL2474694 | 1.00 | GPR84 (0.83) | GPR84PPARGPPARDPPARAHDAC11 | |
| Sebacic Acid SCHEMBL19066940 | 1.00 | GPR84 (0.83) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanedioate SCHEMBL28274642 | 0.97 | GPR84 (0.79) | GPR84PPARGPPARDPPARAHDAC11 | |
| Adipic Acid SCHEMBL8570506 | 0.97 | AKR1B1 (0.82) | GPR84PPARGPPARDPPARAHDAC11 | |
| Adipic Acid SCHEMBL1483012 | 0.97 | AKR1B1 (0.82) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL5046723 | 0.94 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decanoic Acid SCHEMBL6518226 | 0.94 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL15612468 | 0.94 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103275625-A | Adhesive for quickly mutually sticking vulcanized silicone rubbers and preparation method of adhesive | ZHEJIANG LINIZ FINE CHEMICAL CO LTD | 2013-09-04 | — | — | CN | claimed |
| CN-86102433-A | Cleanable writing ink | — | 1987-10-28 | — | — | CN | claimed |
| US-20250025523-A1 | COMPOSITION FOR PREVENTING OR TREATING MUSCLE DISEASE COMPRISING SARGASSUM SERRATIFOLIUM EXTRACT | Pukyong National University Industry- University Cooperation Foundation (KR) | 2025-01-23 | — | — | US | disclosed |
| US-20230173099-A1 | LIPOLYSIS COMPOSITION USING SURFACE-MODIFIED GAS-GENERATING NANOPARTICLES | SUPERNOVA BIO CO., LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
| US-11518735-B2 | Pseudoceramide compound with improved stability and composition comprising same | AE KYUNG INDUSTRIAL CO., LTD. (KR) | 2022-12-06 | — | — | US | disclosed |
| EP-4079299-A1 | LIPOLYSIS COMPOSITION USING SURFACE-MODIFIED GAS-GENERATING NANOPARTICLES | Supernova Bio Co., Ltd. (KR) | 2022-10-26 | — | — | EP | disclosed |
| WO-2021006100-A1 | RUBBER COMPOSITION, METHOD FOR PRODUCING SAME, UNVULCANIZED MOLDED ARTICLE, VULCANIZED PRODUCT, AND VULCANIZED MOLDED ARTICLE | デンカ株式会社 | 2021-01-14 | — | — | WO | disclosed |
| US-20200354309-A1 | NOVEL PSEUDOCERAMIDE COMPOUND WITH IMPROVED STABILITY AND COMPOSITION COMPRISING SAME | AE KYUNG INDUSTRIAL CO., LTD (KR) | 2020-11-12 | — | — | US | disclosed |
| EP-3061448-B1 | COMPOSITION CONTAINING EUGENOL AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ATOPIC DERMATITIS | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2020-07-29 | — | — | EP | disclosed |
| US-10695314-B2 | Antimicrobial composition containing 7,10-epoxyoctadeca-7,9-dienoic acid as active ingredient | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2020-06-30 | — | — | US | disclosed |
| US-20190144603-A1 | THERMOSETTING RESIN COMPOSITION | KYOEISHA CHEMICAL CO., LTD. (JP) | 2019-05-16 | — | — | US | disclosed |
| US-7496324-B2 | Lubricant applying unit and image forming apparatus | RICOH COMPANY, LTD. (JP) | 2009-02-24 | — | — | US | disclosed |
| US-7199173-B2 | Agglomerate and resin composition containing the same | MARUO CALCIUM COMPANY LIMITED (JP) | 2007-04-03 | — | — | US | disclosed |
| WO-2006104336-A1 | COMPOSITION FOR PREVENTION, ALLEVIATION AND TREATMENT OF ATOPYIC DERMATITIS | DAN BIOTECH INC. (KR) | 2006-10-05 | — | — | WO | disclosed |
| US-20060133872-A1 | Lubricant applying unit and image forming apparatus | RICOH COMPANY, LTD. (JP) | 2006-06-22 | — | — | US | disclosed |
| US-20060052503-A1 | Agglomerate and resin composition containing the same | MARUO CALCIUM COMPANY LIMITED (JP) | 2006-03-09 | — | — | US | disclosed |
| CN-1678333-A | Composition containing extract of actinidia arguta and related species for preventing and treating allergic diseases and non-allergic inflammatory diseases | PANGENOMICS CO LTD (KR) | 2005-10-05 | — | — | CN | disclosed |
| US-5892033-A | THERMAL TRANSFER RECORDING; ELECTROSTATIC IMAGING | KONICA CORPORATION (JP) | 1999-04-06 | — | — | US | disclosed |
| EP-0763569-A1 | metal complex methin dye | KONICA CORPORATION (JP) | 1997-03-19 | — | — | EP | disclosed |
| CN-86102433-A | Cleanable writing ink | — | 1987-10-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11518735-B2 | Pseudoceramide compound with improved stability and composition comprising same | CERS2, ASAH2, ASAH1 | GPR84 1339/4885PPARG 2425/4885PPARD 2455/4885 |
| US-20200354309-A1 | NOVEL PSEUDOCERAMIDE COMPOUND WITH IMPROVED STABILITY AND COMPOSITION COMPRISING SAME | CERS2, ASAH2, CERT1 | GPR84 1372/4885PPARG 3069/4885PPARD 3096/4885 |
| US-10695314-B2 | Antimicrobial composition containing 7,10-epoxyoctadeca-7,9-dienoic acid as active ingredient | CYP51A1, IL17A, ELOVL5 | GPR84 3960/4885PPARG 1494/4885PPARD 1417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.